Mandrola Previews the 2019 ACC Meeting Mandrola Previews the 2019 ACC Meeting

The Apple Heart Study will hog the spotlight, but trials on TAVR in low-risk aortic stenosis are more likely to affect practice, says digital-health skeptic John Mandrola, MD. Linkstheheart.org on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news